B7-H3 Antibody / CD276 [Clone B7H3/4348] (Purified)

NSJ Bioreagents
Product Code: NSJ-V4055
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-V4055-20UG20 ug£264.00
Quantity:
NSJ-V4055-100UG100 ug£534.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG2b, kappa
Antibody Clonality: Monoclonal
Antibody Clone: B7H3/4348
Regulatory Status: RUO
Target Species: Human
Application: Immunohistochemistry- Paraffin Embedded (IHC-P)
Storage:
Aliquot the B7-H3 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Images

1 / 1
Analysis of HuProt(TM) microarray containing more than 19,000 full-length human proteins using B7-H3 antibody (clone B7H3/4348). These results demonstrate the foremost specificity of the B7H3/4348 mAb. Z- and S- score: The Z-score represents the strength of a signal that an antibody (in combination with a flu

Analysis of HuProt(TM) microarray containing more than 19,000 full-length human proteins using B7-H3 antibody (clone B7H3/4348). These results demonstrate the foremost specificity of the B7H3/4348 mAb. Z- and S- score: The Z-score represents the strength of a signal that an antibody (in combination with a flu

Documents

Further Information

Application Details:
Immunohistochemistry (FFPE): 1-2ug/ml
Application Note:
Optimal dilution of the B7-H3 antibody should be determined by the researcher.
Description:
T cell activation and immune function are regulated by the innate immune system through positive and negative costimulatory molecules. One such molecule, B7-H3 (B7-homolog 3, also designated B7RP-2 and CD276) belongs to the B7 immunoglobulin superfamily. Soluble B7-H3 binds a putative receptor on activated T-cells that is distinct from CD28, CTLA-4, ICOS and PD-1. Widely expressed on nonlymphoid tissues, B7-H3 costimulates proliferation of both CD4+ and CD8+ T cells. The ability of B7-H3 to stimulate Th1 and cytotoxic-T cell responses suggest that it may have antitumor activity. B7-H3 interactions may play a role in regulating cell-mediated immune responses against cancer, implicating B7-H3 as a potential therapeutic tool.
Format:
Purified
Formulation:
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Immunogen:
A portion of amino acids 100-300 from the human CD276 protein was used as the immunogen for the B7-H3 antibody.
Limitation:
This B7-H3 antibody is available for research use only.
Localization:
Cell surface, cytoplasm
Purity:
Protein A/G affinity
Uniprot #:
Q5ZPR3